A partial description of the structure is included in an article on the tumor inhibiting effects of the antibody: “Potent anti-tumor response by targeting B cell maturation antigen (BCMA) in a mouse model of multiple myeloma”, Mol. Here, TNFRSF17 is linked to plasma cell myeloma.